Rigel Pharmaceuticals Inc (RIGL)
1.075
-0.05
(-4.44%)
USD |
NASDAQ |
Apr 25, 12:35
Rigel Pharmaceuticals Total Liabilities (Quarterly): 145.87M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 145.87M |
| September 30, 2023 | 147.16M |
| June 30, 2023 | 145.21M |
| March 31, 2023 | 147.87M |
| December 31, 2022 | 147.90M |
| September 30, 2022 | 135.44M |
| June 30, 2022 | 131.68M |
| March 31, 2022 | 142.28M |
| December 31, 2021 | 136.95M |
| September 30, 2021 | 136.85M |
| June 30, 2021 | 133.49M |
| March 31, 2021 | 137.70M |
| December 31, 2020 | 76.35M |
| September 30, 2020 | 72.10M |
| June 30, 2020 | 74.82M |
| March 31, 2020 | 64.86M |
| December 31, 2019 | 93.75M |
| September 30, 2019 | 87.15M |
| June 30, 2019 | 77.87M |
| March 31, 2019 | 77.47M |
| December 31, 2018 | 29.23M |
| September 30, 2018 | 19.70M |
| June 30, 2018 | 17.65M |
| March 31, 2018 | 19.01M |
| December 31, 2017 | 18.46M |
| Date | Value |
|---|---|
| September 30, 2017 | 15.08M |
| June 30, 2017 | 15.87M |
| March 31, 2017 | 17.24M |
| December 31, 2016 | 23.11M |
| September 30, 2016 | 22.70M |
| June 30, 2016 | 25.60M |
| March 31, 2016 | 32.83M |
| December 31, 2015 | 40.37M |
| September 30, 2015 | 42.76M |
| June 30, 2015 | 47.20M |
| March 31, 2015 | 53.54M |
| December 31, 2014 | 25.89M |
| September 30, 2014 | 16.37M |
| June 30, 2014 | 16.70M |
| March 31, 2014 | 14.96M |
| December 31, 2013 | 17.81M |
| September 30, 2013 | 16.14M |
| June 30, 2013 | 16.62M |
| March 31, 2013 | 17.63M |
| December 31, 2012 | 20.95M |
| September 30, 2012 | 19.51M |
| June 30, 2012 | 18.61M |
| March 31, 2012 | 17.33M |
| December 31, 2011 | 20.96M |
| September 30, 2011 | 17.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
64.86M
Minimum
Mar 2020
147.90M
Maximum
Dec 2022
117.65M
Average
135.44M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 267.05M |
| Avid Bioservices Inc | 270.97M |
| Stereotaxis Inc | 19.99M |
| Cara Therapeutics Inc | 68.76M |
| Blueprint Medicines Corp | 918.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 117.22M |
| Shareholders Equity (Quarterly) | -28.64M |
| Debt to Equity Ratio | -2.081 |
| Current Ratio | 1.864 |
| Net Debt Paydown Yield | -1.59% |